The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | TTSH TILE SHOP HOLDINGS, INC. | Fund 1 Investments, LLC owner | XIn-the-money exercise Cash-Settled Total Return Swapderivativeindirect: See Footnote | -123,044 | $6.44 | $792k | 482,703 | Dec 11, 2025 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | Gabriel S Morris CFO | XIn-the-money exercise Common Stockindirect: See footnote | +156,000 | $0.80 | $125k | 426,844 | Dec 10, 2025 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | Gabriel S Morris CFO | XIn-the-money exercise Warrants (right to purchase)derivativeindirect: See footnote | -96,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | Gabriel S Morris CFO | XIn-the-money exercise Warrants (right to purchase)derivativeindirect: See footnote | -60,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 5, 2025 | ANGX Angel Studios, Inc. | Elizabeth Ellis Chief Operating Officer | XIn-the-money exercise Class B Common Stock, par value $0.0001 per share | +20,000 | $0.16 | $3,200 | 153,761 | Dec 9, 2025 |
| Dec 5, 2025 | ANGX Angel Studios, Inc. | Elizabeth Ellis Chief Operating Officer | XIn-the-money exercise Stock Option (Right to Buy)derivative | -20,000 | $0.00 | $0 | 129,812 | Dec 9, 2025 |
| Nov 21, 2025 | Q Qnity Electronics, Inc. | Sang Ho Kang President, Semiconductor | XIn-the-money exercise Common Stock | +2,000 | $96.00 | $192k | 16,147 | Dec 9, 2025 |
| Nov 21, 2025 | Q Qnity Electronics, Inc. | Sang Ho Kang President, Semiconductor | XIn-the-money exercise Common Stock | +2,000 | $96.00 | $192k | 18,147 | Dec 9, 2025 |
| Nov 21, 2025 | Q Qnity Electronics, Inc. | Sang Ho Kang President, Semiconductor | XIn-the-money exercise Put Obligation (obligation to buy)derivative | -40 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Nov 21, 2025 | Q Qnity Electronics, Inc. | Sang Ho Kang President, Semiconductor | XIn-the-money exercise Put Obligation (obligation to buy)derivative | -40 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Tremont Realty Capital LLC owner | XIn-the-money exercise Common Shares of Beneficial Interestindirect: By ABP Trust | +58,266 | $8.65 | $504k | 178,488 | Dec 9, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Tremont Realty Capital LLC owner | XIn-the-money exercise Common Shares of Beneficial Interestindirect: By Tremont Realty Capital LLC | +854,029 | $8.65 | $7.4M | 2,562,087 | Dec 9, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Tremont Realty Capital LLC owner | XIn-the-money exercise Subscription Right (Right to Buy)derivativeindirect: By ABP Trust | -116,531 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Tremont Realty Capital LLC owner | XIn-the-money exercise Subscription Right (Right to Buy)derivativeindirect: By Tremont Realty Capital LLC | -1,708,058 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 4, 2025 | ABAT AMERICAN BATTERY TECHNOLOGY Co | Steven Wu Chief Operating Officer | XIn-the-money exercise Common Stock | +50,000 | $1.00 | $50k | 298,569 | Dec 8, 2025 |
| Dec 4, 2025 | ABAT AMERICAN BATTERY TECHNOLOGY Co | Steven Wu Chief Operating Officer | XIn-the-money exercise Warrants to Purchase Common Stockderivative | +50,000 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Common Shares of Beneficial Interest | +109,669 | $8.65 | $949k | 329,009 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Common Shares of Beneficial Interestindirect: See Footnote | +58,266 | $8.65 | $504k | 178,488 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Common Shares of Beneficial Interestindirect: See Footnote | +854,029 | $8.65 | $7.4M | 2,562,087 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -219,340 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Subscription Right (Right to Buy)derivativeindirect: See Footnote | -116,531 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Adam D. Portnoy director, owner | XIn-the-money exercise Subscription Right (Right to Buy)derivativeindirect: See Footnote | -1,708,058 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Matthew C. Brown CFO and Treasurer | XIn-the-money exercise Common Shares of Beneficial Interest | +7,121 | $8.65 | $62k | 21,365 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Matthew C. Brown CFO and Treasurer | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -14,242 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Matthew P. Jordan director | XIn-the-money exercise Common Shares of Beneficial Interest | +6,000 | $8.65 | $52k | 89,136 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Matthew P. Jordan director | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -12,000 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Barbara D. Gilmore director | XIn-the-money exercise Common Shares of Beneficial Interest | +3,000 | $8.65 | $26k | 33,712 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Barbara D. Gilmore director | XIn-the-money exercise Common Shares of Beneficial Interestindirect: By husband | +1,000 | $8.65 | $8,650 | 3,000 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Barbara D. Gilmore director | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -6,000 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Barbara D. Gilmore director | XIn-the-money exercise Subscription Right (Right to Buy)derivativeindirect: By husband | -2,000 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Ann Marie Danner director | XIn-the-money exercise Common Shares of Beneficial Interest | +5,343 | $8.65 | $46k | 16,029 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Ann Marie Danner director | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -10,686 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Thomas J. Lorenzini President and CIO | XIn-the-money exercise Common Shares of Beneficial Interest | +1,918 | $8.65 | $17k | 26,671 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Thomas J. Lorenzini President and CIO | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -3,836 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Joseph Morea director | XIn-the-money exercise Common Shares of Beneficial Interest | +16,339 | $8.65 | $141k | 58,730 | Dec 8, 2025 |
| Dec 4, 2025 | SEVN Seven Hills Realty Trust | Joseph Morea director | XIn-the-money exercise Subscription Right (Right to Buy)derivative | -32,678 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Nov 28, 2025 | JGH Nuveen Global High Income Fund | Young L Robert other | XIn-the-money exercise Common Stock | +4,119 | $12.84 | $53k | 20,595 | Dec 2, 2025 |
| Nov 28, 2025 | JGH Nuveen Global High Income Fund | Young L Robert other | XIn-the-money exercise Subscription Right (right to buy)derivative | -16,476 | $0.00 | $0 | 0 | Dec 2, 2025 |
| Nov 28, 2025 | JGH Nuveen Global High Income Fund | Young L Robert other | XIn-the-money exercise Common Stock | +16,476 | $12.84 | $212k | 32,951 | Dec 1, 2025 |
| Nov 28, 2025 | JGH Nuveen Global High Income Fund | Young L Robert other | XIn-the-money exercise Subscription Rightderivative | -16,476 | $0.00 | $0 | 0 | Dec 1, 2025 |
| Nov 26, 2025 | XLO Xilio Therapeutics, Inc. | Gilead Sciences, Inc. owner | XIn-the-money exercise Prefunded Warrants (right to buy)derivative | +13,335,000 | $0.75 | $10.0M | 36,645,266 | Dec 1, 2025 |
| Nov 26, 2025 | XLO Xilio Therapeutics, Inc. | Gilead Sciences, Inc. owner | XIn-the-money exercise Series B Warrants (right to buy)derivative | -13,335,000 | $0.00 | $0 | 0 | Dec 1, 2025 |
| Nov 25, 2025 | DVLT WISA TECHNOLOGIES, INC. | Scilex Holding Co owner | XIn-the-money exercise Common Stock | +263,914,094 | $0.00 | $26k | 265,524,859 | Nov 28, 2025 |
| Nov 25, 2025 | DVLT WISA TECHNOLOGIES, INC. | Scilex Holding Co owner | XIn-the-money exercise Warrant to Purchase Common Stockderivative | +263,914,094 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 14, 2025 | GCMG GCM Grosvenor Inc. | Michael Jay Sacks Chief Executive Officer | XIn-the-money exercise Class A Common Stockindirect: See footnotes | +900,000 | $11.50 | $10M | 900,000 | Nov 18, 2025 |
| Nov 14, 2025 | GCMG GCM Grosvenor Inc. | Michael Jay Sacks Chief Executive Officer | XIn-the-money exercise Warrantsderivativeindirect: See footnotes | -900,000 | $0.00 | $0 | 0 | Nov 18, 2025 |
| Nov 14, 2025 | ASTS AST SpaceMobile, Inc. | Huiwen Yao Chief Technology Officer | XIn-the-money exercise Class A Common Stock | +40,000 | $0.06 | $2,564 | 44,750 | Nov 17, 2025 |
| Nov 14, 2025 | ASTS AST SpaceMobile, Inc. | Huiwen Yao Chief Technology Officer | XIn-the-money exercise AST LLC Incentive Equity Optionsderivativeindirect: See Footnote | -40,000 | $0.00 | $0 | 339,912 | Nov 17, 2025 |
| Nov 14, 2025 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Warrants to Purchase Series B Common Stock (Right to Buy)derivative | -344,381 | $0.00 | $0 | 2,410,676 | Nov 14, 2025 |
| Nov 14, 2025 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Series B Common Stockderivative | +344,381 | $0.01 | $3,444 | 16,284,344 | Nov 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.